The Chase Group Executive Search Logo
“Committed to Excellence in Life Sciences Executive Search”

Recent News

Partnership with The Chase Group Results in Successful Placement for Eisai Global Oncology Business Unit

March 31, 2020
The Chase Group is proud to partner with Eisai and support their human health care mission by securing a strong and agile leader for their… Continue Reading →

Biologics Consulting Engages Partnership with The Chase Group During Growth

March 27, 2020
Founded on the premise that biotechnology, medical devices, and pharmaceuticals hold the promise of a better future for everyone, Biologics Consulting is making good on… Continue Reading →

Akcea Therapeutics Retains The Chase Group to Secure Senior Vice President for Global Medical Affairs

March 26, 2020
Akcea Therapeutics is driven by determination and focus on addressing the unmet needs and complex medical challenges of patients with serious and rare disorders. As… Continue Reading →

A New Decade, A New Partnership, and Continued Growth for Alexza Pharmaceuticals and The Chase Group

March 24, 2020
At the crossroads of innovation and advanced technology, Alexza Pharmaceuticals is working to develop products for the acute treatment of underserved medical needs in neuroscience…. Continue Reading →

Aeglea Biotherapeutics Secures Another Executive for their Clinical Development Leadership Team

February 24, 2020
To support their rapid growth and expanding portfolio of rare disease programs, Aeglea Biotherapeutics retained The Chase Group and successfully secured a new Global Program… Continue Reading →

The Chase Group is Retained to Secure Multiple Roles for the Eli Lilly Global Oncology Medical Affairs Leadership Team

February 14, 2020
The Chase Group is proud to partner with Eli Lilly and support their commitment to developing innovative, breakthrough medicines that will make a meaningful difference… Continue Reading →

Eisai, Inc. Retains The Chase Group to Build US Medical Affairs Leadership Team

February 11, 2020
Eisai, Inc.’s partnership with Merck has proven to be successful with the FDA approval of the Keytruda and Lenvima Combination Treatment. With 13 indications for… Continue Reading →

Checkmate Pharmaceuticals Partners with The Chase Group to Build Their Clinical Development Team

February 11, 2020
Due to their long-standing relationship, Checkmate’s Chief Medical Officer has again partnered with The Chase Group as he builds his clinical team. Founded in 2015… Continue Reading →

Akcea Retains The Chase Group to Secure Senior HR Leader for the Company’s Executive Team

February 3, 2020
The Chase Group is excited to reengage partnership with Akcea Therapeutics to recruit the company’s Vice President of Human Resources. The Vice President will lead… Continue Reading →

The Chase Group Drug Safety Expertise Utilized by Ionis Pharmaceuticals

December 20, 2019
As the leading innovator in RNA-targeted therapeutics, Ionis Pharmaceuticals requires world-class scientists and business leaders whose passion to innovate is matched only by their commitment… Continue Reading →
© Copyright 1993-2022 The Chase Group; All Rights Reserved.